HEALTHCARE
Global Artificial Intelligence In Pathology Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Artificial Intelligence In Pathology Market, By Component (Software, Scanners), Neural Network (Generative adversarial networks, Convolutional neural networks, Conventional neural network, Recurrent neural networks, Other), Application (Drug discovery, Disease diagnosis and prognosis, Clinical workflow, Training and Education), End User (Pharmaceutical and Biotechnology companies, Hospitals and Reference laboratories, Academic and Research Institutes) Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global artificial intelligence in pathology market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Artificial intelligence (AI) in pathology is the application of advanced algorithms and machine learning approaches to the processing and interpretation of medical pathology data. This technology assists pathologists by using advanced image analysis and data processing to improve diagnostic accuracy, automating the discovery of disease patterns, and classifying tissue samples. AI has the potential to improve pathology workflow, lower diagnostic mistake rates, and facilitate individualized treatment regimens. The Artificial Intelligence in Pathology Market include the creation and implementation of AI-powered technologies and software that help pathologists diagnose diseases more effectively. It consists of AI-powered imaging systems, platforms for diagnosis, and analytical tools for tissue analysis, workflow optimization, and cancer detection. In order to enhance healthcare outcomes and diagnostic accuracy, major companies in this market are concentrating on innovation.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rising demand for accurate and efficient diagnostic tools.
- Increasing adoption of AI for diagnostic imaging and analysis.
RESTRAINTS
- High initial investment and cost of implementation.
- Data privacy and security concerns.
OPPORTUNITIES
- Expansion of AI applications in personalized medicine.
- Collaboration between tech companies and healthcare providers.
CHALLENGES
- Integration of AI systems with existing pathology workflows.
- Need for validation and regulatory approval of AI tools.
SEGMENTATION
- Component
- Software
- Scanners
- Neural Network
- Generative adversarial networks
- Convolutional neural networks
- Conventional neural network
- Recurrent neural networks
- Other
- Application
- Drug discovery
- Disease diagnosis and prognosis
- Clinical workflow
- Training and Education
- End User
- Pharmaceutical and Biotechnology companies
- Hospitals and Reference laboratories
- Academic and Research Institutes
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Aiforia Technologies
- Ibex Medical Analytics
- PROSCIA
- Roche Tissue Diagnostics
- Visiopharm
- Deep Bio
- Mindpeak
- Hologic
- Aiosyn
- Lumea
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Artificial Intelligence In Pathology Market, by Component
- 3.2 Global Artificial Intelligence In Pathology Market, by Neural Network
- 3.3 Global Artificial Intelligence In Pathology Market, by Application
- 3.4 Global Artificial Intelligence In Pathology Market, by End User
- 3.5 Global Artificial Intelligence In Pathology Market, by Geography
- 3.6 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Advancements in AI and machine learning technologies.
- 5.1.2 Integration of AI with digital pathology systems.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising demand for accurate and efficient diagnostic tools.
- 5.2.2 Increasing adoption of AI for diagnostic imaging and analysis.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High initial investment and cost of implementation.
- 5.3.2 Data privacy and security concerns.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Expansion of AI applications in personalized medicine.
- 5.4.2 Collaboration between tech companies and healthcare providers.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Integration of AI systems with existing pathology workflows.
- 5.5.2 Need for validation and regulatory approval of AI tools.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, BY COMPONENT
- 6.1 Component Summary
- 6.2 Market Attractive Index
- 6.3 Global Artificial Intelligence In Pathology Market, by Component (2019-2032)
- SECTION 7 - GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, BY NEURAL NETWORK
- 7.1 Neural Network Summary
- 7.2 Market Attractive Index
- 7.3 Global Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- SECTION 8 - GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, BY APPLICATION
- 8.1 Application Summary
- 8.2 Market Attractive Index
- 8.3 Global Artificial Intelligence In Pathology Market, by Application (2019-2032)
- SECTION 9 - GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, BY END USER
- 9.1 End User Summary
- 9.2 Market Attractive Index
- 9.3 Global Artificial Intelligence In Pathology Market, by End User (2019-2032)
- SECTION 10 - GLOBAL ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET, BY GEOGRAPHY
- 10.1 Regional Summary
- 10.2 Market Attractive Index
- 10.3 Global Artificial Intelligence In Pathology Market, by Geography (2019-2032)
- SECTION 11 - NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET
- 11.1 North America Summary
- 11.2 Market Attractive Index
- 11.3 North America Artificial Intelligence In Pathology Market, by Component (2019-2032)
- 11.4 North America Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- 11.5 North America Artificial Intelligence In Pathology Market, by Application (2019-2032)
- 11.6 North America Artificial Intelligence In Pathology Market, by End User (2019-2032)
- 11.7 North America Artificial Intelligence In Pathology Market, by Country (2019-2032)
- 11.7.1 U.S.
- 11.7.2 Canada
- 11.7.3 Mexico
- 11.7.4 Rest of North America
- SECTION 12 - EUROPE ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET
- 12.1 Europe Summary
- 12.2 Market Attractive Index
- 12.3 Europe Artificial Intelligence In Pathology Market, by Component (2019-2032)
- 12.4 Europe Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- 12.5 Europe Artificial Intelligence In Pathology Market, by Application (2019-2032)
- 12.6 Europe Artificial Intelligence In Pathology Market, by End User (2019-2032)
- 12.7 Europe Artificial Intelligence In Pathology Market, by Country (2019-2032)
- 12.7.1 Germany
- 12.7.2 U.K.
- 12.7.3 France
- 12.7.4 Italy
- 12.7.5 Spain
- 12.7.6 Russia
- 12.7.7 The Netherlands
- 12.7.8 Belgium
- 12.7.9 Turkey
- 12.7.10 Rest of Europe
- SECTION 13 - ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET
- 13.1 Asia-Pacific Summary
- 13.2 Market Attractive Index
- 13.3 Asia-Pacific Artificial Intelligence In Pathology Market, by Component (2019-2032)
- 13.4 Asia-Pacific Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- 13.5 Asia-Pacific Artificial Intelligence In Pathology Market, by Application (2019-2032)
- 13.6 Asia-Pacific Artificial Intelligence In Pathology Market, by End User (2019-2032)
- 13.7 Asia-Pacific Artificial Intelligence In Pathology Market, by Country (2019-2032)
- 13.7.1 China
- 13.7.2 India
- 13.7.3 Japan
- 13.7.4 South Korea
- 13.7.5 Singapore
- 13.7.6 Malaysia
- 13.7.7 Australia
- 13.7.8 Thailand
- 13.7.9 Philippines
- 13.7.10 Rest of Asia-Pacific
- SECTION 14 - SOUTH AMERICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET
- 14.1 South America Summary
- 14.2 Market Attractive Index
- 14.3 South America Artificial Intelligence In Pathology Market, by Component (2019-2032)
- 14.4 South America Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- 14.5 South America Artificial Intelligence In Pathology Market, by Application (2019-2032)
- 14.6 South America Artificial Intelligence In Pathology Market, by End User (2019-2032)
- 14.7 South America Artificial Intelligence In Pathology Market, by Country (2019-2032)
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Chile
- 14.7.4 Colombia
- 14.7.5 Rest of South America
- SECTION 15 - MIDDLE EAST AND AFRICA ARTIFICIAL INTELLIGENCE IN PATHOLOGY MARKET
- 15.1 Middle East and Africa Summary
- 15.2 Market Attractive Index
- 15.3 Middle East and Africa Artificial Intelligence In Pathology Market, by Component (2019-2032)
- 15.4 Middle East and Africa Artificial Intelligence In Pathology Market, by Neural Network (2019-2032)
- 15.5 Middle East and Africa Artificial Intelligence In Pathology Market, by Application (2019-2032)
- 15.6 Middle East and Africa Artificial Intelligence In Pathology Market, by End User (2019-2032)
- 15.7 Middle East and Africa Artificial Intelligence In Pathology Market, by Country (2019-2032)
- 15.7.1 Kingdom of Saudi Arabia
- 15.7.2 South Africa
- 15.7.3 U.A.E.
- 15.7.4 Egypt
- 15.7.5 Rest of Middle East and Africa
- SECTION 16 - COMPANY SHARE ANALYSIS
- 16.1 Global Artificial Intelligence In Pathology Market, Company Share Analysis
- 16.2 North America Artificial Intelligence In Pathology Market, Company Share Analysis
- 16.3 Europe Artificial Intelligence In Pathology Market, Company Share Analysis
- 16.4 Asia-Pacific Artificial Intelligence In Pathology Market, Company Share Analysis
- SECTION 17 - COMPANY PROFILES
- 17.1 Aiforia Technologies
- 17.1.1 Company Snapshot
- 17.1.2 Financial Overview
- 17.1.3 Product Portfolio
- 17.1.4 Recent Developments
- 17.2 Ibex Medical Analytics
- 17.2.1 Company Snapshot
- 17.2.2 Financial Overview
- 17.2.3 Product Portfolio
- 17.2.4 Recent Developments
- 17.3 PROSCIA
- 17.3.1 Company Snapshot
- 17.3.2 Financial Overview
- 17.3.3 Product Portfolio
- 17.3.4 Recent Developments
- 17.4 Roche Tissue Diagnostics
- 17.4.1 Company Snapshot
- 17.4.2 Financial Overview
- 17.4.3 Product Portfolio
- 17.4.4 Recent Developments
- 17.5 Visiopharm
- 17.5.1 Company Snapshot
- 17.5.2 Financial Overview
- 17.5.3 Product Portfolio
- 17.5.4 Recent Developments
- 17.6 Deep Bio
- 17.6.1 Company Snapshot
- 17.6.2 Financial Overview
- 17.6.3 Product Portfolio
- 17.6.4 Recent Developments
- 17.7 Mindpeak
- 17.7.1 Company Snapshot
- 17.7.2 Financial Overview
- 17.7.3 Product Portfolio
- 17.7.4 Recent Developments
- 17.8 Hologic
- 17.8.1 Company Snapshot
- 17.8.2 Financial Overview
- 17.8.3 Product Portfolio
- 17.8.4 Recent Developments
- 17.9 Aiosyn
- 17.9.1 Company Snapshot
- 17.9.2 Financial Overview
- 17.9.3 Product Portfolio
- 17.9.4 Recent Developments
- 17.10 Lumea
- 17.10.1 Company Snapshot
- 17.10.2 Financial Overview
- 17.10.3 Product Portfolio
- 17.10.4 Recent Developments
- SECTION 18 - RELATED REPORTS
- SECTION 19 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.